217 filings
Page 4 of 11
8-K
9dyw nyj0
9 Nov 07
Other Events
12:00am
8-K
vqr85ibyp1jsdlp
25 Oct 07
AtheroGenics Reports Third Quarter 2007 Financial Results
12:00am
8-K
tfq7lxb6yn sv
23 Oct 07
Departure of Directors or Principal Officers
12:00am
8-K
awut69es
26 Jul 07
AtheroGenics Reports Second Quarter 2007 Financial Results
12:00am
8-K
bexy2vbfsltserwcu
19 Jul 07
Other Events
12:00am
8-K
aplhufds v2m7ee3r366
12 Jul 07
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
mkr39a65x uf64s
25 Jun 07
Unregistered Sales of Equity Securities
12:00am
8-K
o7gum3lxtg
22 Jun 07
Departure of Directors or Principal Officers
12:00am
8-K
6ox9q woe6gdn
1 Jun 07
AtheroGenics Announces Business Plan to Focus on Advancing AGI-1067 in Diabetes
12:00am
8-K
8zmxv32rfonzj1v dvt
25 May 07
Other Events
12:00am
ARS
w4b65u8
3 May 07
Annual report to shareholders
12:00am
8-K
laz7ad7izqw20k
26 Apr 07
AtheroGenics Reports First Quarter 2007 Financial Results
12:00am
8-K
5uz sttq8scdfpw
24 Apr 07
AtheroGenics and AstraZeneca End Collaboration Agreement for AGI-1067
12:00am
8-K
1jh yxweplr13zch
19 Apr 07
Departure of Directors or Principal Officers
12:00am
8-K
7mli e55bh7a8fdjny
27 Mar 07
AtheroGenics Announces ARISE Phase III Clinical Study Results at the American College of Cardiology’s 56th Annual Scientific Session
12:00am
8-K
0cxqyden4frmmjx3
19 Mar 07
AtheroGenics Reports ARISE Trial Results for AGI-1067
12:00am